Back to Search
KYLE LUNDGREN, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1184006686Individual
Specialties, Licenses & Credentials
Research & Publications (20)
BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy.
PMID 19662650·Int J Cancer·2010
7-preclinical
BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance.
PMID 19676042·Int J Cancer·2010
7-preclinical
Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
PMID 19671844·Clin Cancer Res·2009
7-preclinical
Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats.
PMID 19505538·Neuroscience·2009
7-preclinical
Metabolomic evaluation of pulsed electric field-induced stress on potato tissue.
PMID 19495789·Planta·2009
8-other
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
PMID 19372565·Mol Cancer Ther·2009
7-preclinical
Arabidopsis sterol carrier protein-2 is required for normal development of seeds and seedlings.
PMID 18687588·J Exp Bot·2008
8-other
Using lexical familiarity judgments to assess verbally mediated intelligence in aphasia.
PMID 18999341·Neuropsychology·2008
3-trial
Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
PMID 18823530·Breast Cancer Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 474 CHAMBERLAIN HWY
MERIDEN, CT 06451 - Phone
- (860) 618-4008
Quick Facts
- NPI
- 1184006686
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile